Other Species / Isoforms
  IRTKS (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
Y16-p
NRLTESTyRNVMEQF
1 11
IRTKS (human) NRLTESTyRNVMEQF Y16-p
IRTKS (mouse) NRLTENTYRNVMEQF Y16
IRTKS (rat) NRLTENTYRNVVEQF Y16
Y37-p
LINLGKNyEkAVNAM
1 0
IRTKS (human) LINLGKNyEkAVNAM Y37-p
IRTKS (mouse) LINLGKNYEkAVNAM Y37
IRTKS (rat) LINLGKNYEKAVNAM Y37
K39-ub
NLGKNyEkAVNAMIL
0 2
IRTKS (human) NLGKNyEkAVNAMIL K39-ub
IRTKS (mouse) NLGKNYEkAVNAMIL K39-ub
IRTKS (rat) NLGKNYEKAVNAMIL K39
Y51-p
MILAGKAyYDGVAKI
0 1
IRTKS (human) MILAGKAyYDGVAKI Y51-p
IRTKS (mouse) MILAGKAYYDGVAKI Y51
IRTKS (rat) MILAGKAYYDGVAKI Y51
T63-p
AKIGEIAtGSPVSTE
0 1
IRTKS (human) AKIGEIAtGSPVSTE T63-p
IRTKS (mouse) AKIGEIATGSPVSTE T63
IRTKS (rat) AKIGEIATGSPVSTE T63
K84-ub
EISSTHKkLNESLDE
0 1
IRTKS (human) EISSTHKkLNESLDE K84-ub
IRTKS (mouse) EISSTHKKLNETLDE K84
IRTKS (rat) EISSTHKKLNETLDE K84
K94-ac
ESLDENFkKFHkEII
0 1
IRTKS (human) ESLDENFkKFHkEII K94-ac
IRTKS (mouse) ETLDENFKKFHKDII K94
IRTKS (rat) ETLDENFKKFHkEII K94
K94-ub
ESLDENFkKFHkEII
0 1
IRTKS (human) ESLDENFkKFHkEII K94-ub
IRTKS (mouse) ETLDENFKKFHKDII K94
IRTKS (rat) ETLDENFKKFHkEII K94
K98
ENFkKFHKEIIHELE
0 1
IRTKS (human) ENFkKFHKEIIHELE K98
IRTKS (mouse) ENFKKFHKDIIHELE K98
IRTKS (rat) ENFKKFHkEIIHELE K98-ac
K98-ub
ENFkKFHkEIIHELE
0 1
IRTKS (human) ENFkKFHkEIIHELE K98-ub
IRTKS (mouse) ENFKKFHKDIIHELE K98
IRTKS (rat) ENFKKFHKEIIHELE K98
K106
EIIHELEKKIELDVK
0 1
IRTKS (human) EIIHELEKKIELDVK K106
IRTKS (mouse) DIIHELEKKTELDVK K106
IRTKS (rat) EIIHELEkKTELDVK K106-ac
Y114-p
KIELDVKyMNAtLKR
1 2
IRTKS (human) KIELDVKyMNAtLKR Y114-p
IRTKS (mouse) KTELDVKYMNATLKR Y114
IRTKS (rat) KTELDVKYMNAtLKR Y114
T118-p
DVKyMNAtLKRYQTE
0 3
IRTKS (human) DVKyMNAtLKRYQTE T118-p
IRTKS (mouse) DVKYMNATLKRYQAE T118
IRTKS (rat) DVKYMNAtLKRYQAE T118-p
S132-p
EHKNKLEsLEKsQAE
0 1
IRTKS (human) EHKNKLEsLEKsQAE S132-p
IRTKS (mouse) EHRNKLDSLEKSQAE S132
IRTKS (rat) EHRNKLDSLEKSQAE S132
S136-p
KLEsLEKsQAELKKI
0 1
IRTKS (human) KLEsLEKsQAELKKI S136-p
IRTKS (mouse) KLDSLEKSQAELKKI S136
IRTKS (rat) KLDSLEKSQAELKKI S136
K146-ub
ELKKIRRksQGsRNA
0 1
IRTKS (human) ELKKIRRksQGsRNA K146-ub
IRTKS (mouse) ELKKIRRKSQGGRNA K146
IRTKS (rat) ELKKIRRKSQGGRNA K146
S147-p
LKKIRRksQGsRNAL
0 2
IRTKS (human) LKKIRRksQGsRNAL S147-p
IRTKS (mouse) LKKIRRKSQGGRNAL S147
IRTKS (rat) LKKIRRKSQGGRNAL S147
S150-p
IRRksQGsRNALkyE
0 1
IRTKS (human) IRRksQGsRNALkyE S150-p
IRTKS (mouse) IRRKSQGGRNALKYE G150
IRTKS (rat) IRRKSQGGRNALKYE G150
K155-ub
QGsRNALkyEHKEIE
0 1
IRTKS (human) QGsRNALkyEHKEIE K155-ub
IRTKS (mouse) QGGRNALKYEHKEIE K155
IRTKS (rat) QGGRNALKYEHKEIE K155
Y156-p
GsRNALkyEHKEIEy
1 32
IRTKS (human) GsRNALkyEHKEIEy Y156-p
IRTKS (mouse) GGRNALKYEHKEIEY Y156
IRTKS (rat) GGRNALKYEHKEIEy Y156
Y163-p
yEHKEIEyVEtVTSR
1 100
IRTKS (human) yEHKEIEyVEtVTSR Y163-p
IRTKS (mouse) YEHKEIEYVETVTSR Y163
IRTKS (rat) YEHKEIEyVETVTSR Y163-p
T166-p
KEIEyVEtVTSRQSE
0 2
IRTKS (human) KEIEyVEtVTSRQSE T166-p
IRTKS (mouse) KEIEYVETVTSRQSE T166
IRTKS (rat) KEIEyVETVTSRQSE T166
K183-ub
KFIADGCkEALLEEK
0 1
IRTKS (human) KFIADGCkEALLEEK K183-ub
IRTKS (mouse) KFIADGCKEALLEEK K183
IRTKS (rat) KFIADGCKEALLEEK K183
K234-ub
ETCVDAIkVPEkIMN
0 2
IRTKS (human) ETCVDAIkVPEkIMN K234-ub
IRTKS (mouse) ETCCDATKVPEKIMN K234
IRTKS (rat) ETCCDATKVPEKIMN K234
K238-ub
DAIkVPEkIMNMIEE
0 2
IRTKS (human) DAIkVPEkIMNMIEE K238-ub
IRTKS (mouse) DATKVPEKIMNMIEE K238
IRTKS (rat) DATKVPEKIMNMIEE K238
T248-p
NMIEEIKtPAstPVs
Upstream
0 12
Treatment
  • LPA
  • nocodazole
IRTKS (human) NMIEEIKtPAstPVs T248-p
IRTKS (mouse) NMIEEIKtPIstPVs T248-p
IRTKS (rat) NMIEEIKTPISTPVs T248
S251-p
EEIKtPAstPVsGtP
0 7
IRTKS (human) EEIKtPAstPVsGtP S251-p
IRTKS (mouse) EEIKtPIstPVsGtP S251-p
IRTKS (rat) EEIKTPISTPVsGtP S251
T252-p
EIKtPAstPVsGtPQ
Upstream
0 12
Treatment
  • metastatic potential
IRTKS (human) EIKtPAstPVsGtPQ T252-p
IRTKS (mouse) EIKtPIstPVsGtPQ T252-p
IRTKS (rat) EIKTPISTPVsGtPQ T252
S255-p
tPAstPVsGtPQAsP
Upstream
0 12
Treatment
  • metastatic potential
IRTKS (human) tPAstPVsGtPQAsP S255-p
IRTKS (mouse) tPIstPVsGtPQPsP S255-p
IRTKS (rat) TPISTPVsGtPQPsP S255-p
T257-p
AstPVsGtPQAsPMI
Upstream
0 48
Regulatory protein:
  • PRP4 (human)
Treatment
  • BI2536
  • LPA
  • metastatic potential
  • nocodazole
IRTKS (human) AstPVsGtPQAsPMI T257-p
IRTKS (mouse) IstPVsGtPQPsPMI T257-p
IRTKS (rat) ISTPVsGtPQPsPMT T257-p
S261-p
VsGtPQAsPMIERSN
Upstream
0 65
Regulatory protein:
  • PRP4 (human)
Treatment
  • BI2536
  • ischemia
  • LPA
  • metastatic potential
  • nocodazole
IRTKS (human) VsGtPQAsPMIERSN S261-p
IRTKS (mouse) VsGtPQPsPMIERSK S261-p
IRTKS (rat) VsGtPQPsPMTERSK S261-p
Y274-p
SNVVRKDyDtLskCs
Upstream
1 235
Treatment
  • gefitinib
  • imatinib
  • Su11274
IRTKS (human) SNVVRKDyDtLskCs Y274-p
IRTKS (mouse) SKMIGKDyDtLsKys Y274-p
IRTKS (rat) SKMIGKDYDTLSKys Y274
T276-p
VVRKDyDtLskCsPK
0 31
IRTKS (human) VVRKDyDtLskCsPK T276-p
IRTKS (mouse) MIGKDyDtLsKysPK T276-p
IRTKS (rat) MIGKDYDTLSKysPK T276
S278-p
RKDyDtLskCsPKMP
0 8
IRTKS (human) RKDyDtLskCsPKMP S278-p
IRTKS (mouse) GKDyDtLsKysPKMP S278-p
IRTKS (rat) GKDYDTLSKysPKMP S278
K279-ub
KDyDtLskCsPKMPP
0 1
IRTKS (human) KDyDtLskCsPKMPP K279-ub
IRTKS (mouse) KDyDtLsKysPKMPP K279
IRTKS (rat) KDYDTLSKysPKMPP K279
C280
DyDtLskCsPKMPPA
0 2
IRTKS (human) DyDtLskCsPKMPPA C280
IRTKS (mouse) DyDtLsKysPKMPPA Y280-p
IRTKS (rat) DYDTLSKysPKMPPA Y280-p
S281-p
yDtLskCsPKMPPAP
0 58
IRTKS (human) yDtLskCsPKMPPAP S281-p
IRTKS (mouse) yDtLsKysPKMPPAP S281-p
IRTKS (rat) YDTLSKysPKMPPAP S281-p
Y293-p
PAPSGRAytsPLIDM
1 21
IRTKS (human) PAPSGRAytsPLIDM Y293-p
IRTKS (mouse) PAPSVKAYTSPLIDM Y293
IRTKS (rat) PAPSVKAYTSPLIDM Y293
T294-p
APSGRAytsPLIDMF
0 2
IRTKS (human) APSGRAytsPLIDMF T294-p
IRTKS (mouse) APSVKAYTSPLIDMF T294
IRTKS (rat) APSVKAYTSPLIDMF T294
S295-p
PSGRAytsPLIDMFN
0 2
IRTKS (human) PSGRAytsPLIDMFN S295-p
IRTKS (mouse) PSVKAYTSPLIDMFN S295
IRTKS (rat) PSVKAYTSPLIDMFN S295
V314
AAPNSQRVNNSTGTS
0 1
IRTKS (human) AAPNSQRVNNSTGTS V314
IRTKS (mouse) AAQSSEKtNNSTANT T314-p
IRTKS (rat) AGQSAEKTNNSTANT T314
S329-p
EDPSLQRsVsVAtGL
0 6
IRTKS (human) EDPSLQRsVsVAtGL S329-p
IRTKS (mouse) EDPSLQRsVsVAtGL S330-p
IRTKS (rat) DDPSLQRSVsVATGL S330
S331-p
PSLQRsVsVAtGLNM
Upstream
Downstream
1 39
Effects on Modified Protein
  • molecular association, regulation
Kinase, in vitro:
  • Chk2 (human)
Treatment
  • ischemia
IRTKS (human) PSLQRsVsVAtGLNM S331-p
IRTKS (mouse) PSLQRsVsVAtGLNM S332-p
IRTKS (rat) PSLQRSVsVATGLNM S332-p
T334-p
QRsVsVAtGLNMMKK
0 2
IRTKS (human) QRsVsVAtGLNMMKK T334-p
IRTKS (mouse) QRsVsVAtGLNMMKK T335-p
IRTKS (rat) QRSVsVATGLNMMKK T335
T351-p
VKTIFPHtAGsNKTL
0 1
IRTKS (human) VKTIFPHtAGsNKTL T351-p
IRTKS (mouse) VKTIFPHTAGNNKTL T352
IRTKS (rat) VKTIFPHTAGNNKTL T352
S354-p
IFPHtAGsNKTLLSF
0 7
IRTKS (human) IFPHtAGsNKTLLSF S354-p
IRTKS (mouse) IFPHTAGNNKTLLSF N355
IRTKS (rat) IFPHTAGNNKTLLSF N355
Y380-p
EEKDGWLyGEHDVSK
0 3
IRTKS (human) EEKDGWLyGEHDVSK Y380-p
IRTKS (mouse) EEKDGWLYGEHDTTK Y381
IRTKS (rat) EEKDGWLYGEHDTTK Y381
S394-p
KARGWFPssytKLLE
0 1
IRTKS (human) KARGWFPssytKLLE S394-p
IRTKS (mouse) KARGWFPSSYTKLLE S395
IRTKS (rat) KVRGWFPSSYTKLLE S395
S395-p
ARGWFPssytKLLEE
0 2
IRTKS (human) ARGWFPssytKLLEE S395-p
IRTKS (mouse) ARGWFPSSYTKLLEE S396
IRTKS (rat) VRGWFPSSYTKLLEE S396
Y396-p
RGWFPssytKLLEEN
0 1
IRTKS (human) RGWFPssytKLLEEN Y396-p
IRTKS (mouse) RGWFPSSYTKLLEEN Y397
IRTKS (rat) RGWFPSSYTKLLEEN Y397
T397-p
GWFPssytKLLEENE
0 1
IRTKS (human) GWFPssytKLLEENE T397-p
IRTKS (mouse) GWFPSSYTKLLEENE T398
IRTKS (rat) GWFPSSYTKLLEENM T398
T409-p
ENETEAVtVPtPsPt
0 3
IRTKS (human) ENETEAVtVPtPsPt T409-p
IRTKS (mouse) LEENEAMSVPtPsPA S408
IRTKS (rat) ENMKEAMSVPTPSSA S410
T412-p
TEAVtVPtPsPtPVR
Upstream
0 26
Treatment
  • nocodazole
IRTKS (human) TEAVtVPtPsPtPVR T412-p
IRTKS (mouse) NEAMSVPtPsPAPVR T411-p
IRTKS (rat) KEAMSVPTPSSAPVR T413
S414-p
AVtVPtPsPtPVRsI
Upstream
0 82
Treatment
  • dasatinib
IRTKS (human) AVtVPtPsPtPVRsI S414-p
IRTKS (mouse) AMSVPtPsPAPVRsI S413-p
IRTKS (rat) AMSVPTPSSAPVRSI S415
T416-p
tVPtPsPtPVRsIst
Upstream
0 20
Treatment
  • nocodazole
  • Y27632
IRTKS (human) tVPtPsPtPVRsIst T416-p
IRTKS (mouse) SVPtPsPAPVRsIst A415
IRTKS (rat) SVPTPSSAPVRSIsT A417
S420-p
PsPtPVRsIstVNLS
0 23
IRTKS (human) PsPtPVRsIstVNLS S420-p
IRTKS (mouse) PsPAPVRsIstVDLT S419-p
IRTKS (rat) PSSAPVRSIsTVDLT S421
S422-p
PtPVRsIstVNLSEN
0 176
IRTKS (human) PtPVRsIstVNLSEN S422-p
IRTKS (mouse) PAPVRsIstVDLTEK S421-p
IRTKS (rat) SAPVRSIsTVDLTEK S423-p
T423-p
tPVRsIstVNLSENS
0 39
IRTKS (human) tPVRsIstVNLSENS T423-p
IRTKS (mouse) APVRsIstVDLTEKS T422-p
IRTKS (rat) APVRSIsTVDLTEKS T424
Y439-p
VVIPPPDyLECLsMG
1 3
IRTKS (human) VVIPPPDyLECLsMG Y439-p
IRTKS (mouse) VVIPPPDYLECLSMG Y438
IRTKS (rat) VVIPPPDYLECLSMG Y440
S444-p
PDyLECLsMGAAADR
0 2
IRTKS (human) PDyLECLsMGAAADR S444-p
IRTKS (mouse) PDYLECLSMGATSDK S443
IRTKS (rat) PDYLECLSMGATSDK S445
T494-p
SGENPFAtVkLRPTV
0 1
IRTKS (human) SGENPFAtVkLRPTV T494-p
IRTKS (mouse) SGENPFATVKLRPTV T497
IRTKS (rat) SGENPFATVKLRPTV T499
K496-ub
ENPFAtVkLRPTVTN
0 1
IRTKS (human) ENPFAtVkLRPTVTN K496-ub
IRTKS (mouse) ENPFATVKLRPTVTN K499
IRTKS (rat) ENPFATVKLRPTVTN K501
R505-m1
RPTVTNDrSAPIIR_
0 1
IRTKS (human) RPTVTNDrSAPIIR_ R505-m1
IRTKS (mouse) RPTVTNDRSAPIIR_ R508
IRTKS (rat) RPTVTNDRSAPIIR_ R510